Duration of Breastfeeding Interruption in Nuclear Medicine Procedures.

The recommendation for the duration of breastfeeding interruption after radiopharmaceutical administration has not been standardized and varies among the guidance documents and publications in the literature. Methods: A working group consisting of 3 staff physicians, 2 fellows, and 2 technologists was designated to update the institutional recommendations on breastfeeding interruption based on the review of the guidance documents and the literature. Results: Our institutional recommendations on the duration of breastfeeding interruption for 54 radiopharmaceuticals are presented in 4 summary tables. For completeness, we also include other radiopharmaceuticals with available information. Conclusion: The detailed recommendation summary on breastfeeding might be helpful to other centers.

Thyroid Uptake Exceeding 100%: Causes and Prevention.

Background: Radionuclide thyroid uptake measurements reflect the metabolic activity of the thyroid gland. Thyroid uptake is measured as a percentage of radioactivity retained by the gland at a specified time versus the activity administered to the patient; thus, uptake measurements must fall between 0 and 100%. In this study we review sources of errors that can lead to uptake >100% through a case study and describe a novel quality control (QC) indicator to improve the accuracy of uptake measurements in the clinic. Methods: Probe efficiency is determined as the ratio between dose counts of the probe relative to the independent dose calibrator activity readings. The nominal probe efficiency value (M) was calculated as the mean of readings (n≥20) and variance was characterized using the standard-deviation (SD). Warning levels were set at M±1.96×SD and error levels were set to M±2.58×SD. In subsequent routine clinical use, prior to administrating a capsule, the probe efficiency is calculated and compared with the warning and error limits. We derived M for three pairs of probe and dose-calibrator devices using several doses and measured independently by several nuclear medicine technologists. Results: The recorded data indicated that nominal efficiency was statistically different between our old device and the one that replaced it (P = 0.01) but coefficient-of-variation(CV% =SD/M×100%) was not (P = 0.42) when technologists were made aware of the expected efficiency value. Using efficiency measurements of the first 20 first patients acquired on the replacement device new QC values were derived (M= 910, SD =36). In 22 patients measured at our sister site, with the same device models but without technologists being aware of QC initiative, derived QC values were (M =1025, SD =116), demonstrating a significant difference between nominal values of individual devices (p<0.001). Furthermore, variability was significantly lower (p<0.001) when QC was followed compared to when it was not applied. Conclusion: Adding the probe efficiency as a quality control indicator during thyroid uptake measurement is simple, can produce more precise clinical measurement and help mitigate operator and instrumentation errors.